pertuzumab,pembrolizumab,dostarlimab,talazoparib,durvalumab,trastuzumab,olaparib,paclitaxel,neratinib,cemiplimab,ganetespib,irinotecan,tucatinib
gsk,bms,amgen,astrazeneca,daiichi sankyo,merck,roche
['i-spy', 'so proud']
so proud of senior fellow #asco22 presenting the i-spy2 evaluation of pcr by mp/blueprint/immune signature in hr+/her2- disease. game changer - i-spy2.2 is the next generation of trials - and the future is now. 